ONTOLOGY REPORT - ANNOTATIONS
| Term: | ampicillin |
|
| Accession: | CHEBI:28971
|
browse the term
|
| Definition: | A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group. |
| Synonyms: | exact_synonym: | 6beta-[(2R)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic acid |
| | related_synonym: | (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID; (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(D-(2-amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; ABPC; AMP; AP; C16H19N3O4S; D-(-)-6-(alpha-aminophenylacetamido)penicillanic acid; D-(-)-ampicillin; InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1; InChIKey=AVKUERGKIZMTKX-NJBDSQKTSA-N; [H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1)C(O)=O; aminobenzylpenicillin; ampicilina; ampicillin acid; ampicillin anhydrous; ampicilline; ampicillinum |
| | alt_id: | CHEBI:22536; CHEBI:2683; CHEBI:40648; CHEBI:45042 |
| | xref_casrn: | 69-53-4 |
| | xref: | Beilstein:4300240 "Beilstein Registry Number"; ChEMBL:405519 "ChEMBL COMPOUND"; ChemIDplus:69-53-4 "CAS Registry Number"; CiteXplore:10930630 "PubMed citation"; CiteXplore:12569987 "PubMed citation"; CiteXplore:12833570 "PubMed citation"; CiteXplore:16033609 "PubMed citation"; CiteXplore:2083978 "PubMed citation"; CiteXplore:6176550 "PubMed citation"; DrugBank:DB00415 "DrugBank"; KEGG COMPOUND:C06574 "KEGG COMPOUND"; KEGG DRUG:D00204 "KEGG DRUG" |
| | xref_mesh: | MESH:D000667 |
| | xref: | PDB:1H8S "PDB"; PDBeChem:AIC "PDBeChem"; Patent:GB902703 "Patent"; Patent:US2985648 "Patent"; Patent:US3157640 "Patent"; Reaxys:4300240 "Reaxys Registry Number"; Wikipedia:Ampicillin "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:50658 |
|
|
ampicillin
|
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
decreases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases transport |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Agpat9 |
1-acylglycerol-3-phosphate O-acyltransferase 9 |
|
decreases expression |
ISO |
14 |
9,998,566 |
10,050,154 |
RGD:6480464 |
CTD |
| G |
Akr1b10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
|
decreases expression |
ISO |
4 |
61,755,871 |
61,771,264 |
RGD:6480464 |
CTD |
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
decreases expression |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
| G |
Amot |
angiomotin |
|
increases expression |
ISO |
X |
33,018,434 |
33,062,515 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 |
|
increases expression |
ISO |
1 |
240,316,123 |
240,324,804 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
decreases expression |
ISO |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
increases expression |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
increases expression |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arrdc3 |
arrestin domain containing 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
decreases expression |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases response to substance |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Car9 |
carbonic anhydrase 9 |
|
increases expression |
ISO |
5 |
59,986,413 |
59,993,015 |
RGD:6480464 |
CTD |
| G |
Ccpg1 |
cell cycle progression 1 |
|
decreases expression |
ISO |
8 |
77,724,315 |
77,768,060 |
RGD:6480464 |
CTD |
| G |
Chst15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
|
increases expression |
ISO |
1 |
191,708,603 |
191,737,958 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Clgn |
calmegin |
|
decreases expression |
ISO |
19 |
26,404,126 |
26,436,081 |
RGD:6480464 |
CTD |
| G |
Clic3 |
chloride intracellular channel 3 |
|
increases expression |
ISO |
3 |
3,622,894 |
3,624,805 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
increases expression |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
|
decreases expression |
ISO |
7 |
10,106,525 |
10,114,960 |
RGD:6480464 |
CTD |
| G |
Csta |
cystatin A (stefin A) |
|
decreases expression |
ISO |
11 |
66,456,248 |
66,467,253 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
3 |
161,542,131 |
161,553,801 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
increases expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp7 |
dual specificity phosphatase 7 |
|
increases expression |
ISO |
8 |
111,510,358 |
111,515,989 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Esm1 |
endothelial cell-specific molecule 1 |
|
decreases expression |
ISO |
2 |
44,626,010 |
44,634,748 |
RGD:6480464 |
CTD |
| G |
Filip1l |
filamin A interacting protein 1-like |
|
increases expression |
ISO |
11 |
43,788,676 |
43,859,932 |
RGD:6480464 |
CTD |
| G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
|
increases expression |
ISO |
1 |
86,095,551 |
86,098,079 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
decreases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
decreases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Hoxd1 |
homeo box D1 |
|
increases expression |
ISO |
3 |
57,377,839 |
57,379,978 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Jdp2 |
Jun dimerization protein 2 |
|
decreases expression |
ISO |
6 |
109,708,745 |
109,740,375 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
increases expression |
ISO |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Lppr1 |
lipid phosphate phosphatase-related protein type 1 |
|
increases expression |
ISO |
5 |
65,982,029 |
66,115,218 |
RGD:6480464 |
CTD |
| G |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
|
increases expression |
ISO |
1 |
186,201,083 |
186,204,364 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mtss1l |
metastasis suppressor 1-like |
|
increases expression |
ISO |
19 |
40,640,947 |
40,661,240 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Pa2g4 |
proliferation-associated 2G4 |
|
increases expression |
ISO |
7 |
1,846,628 |
1,854,096 |
RGD:6480464 |
CTD |
| G |
Pabpc1l |
poly(A) binding protein, cytoplasmic 1-like |
|
decreases expression |
ISO |
3 |
154,959,889 |
154,992,338 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
increases expression |
ISO |
19 |
307,961 |
312,004 |
RGD:6480464 |
CTD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
increases expression |
ISO |
17 |
78,241,182 |
78,268,272 |
RGD:6480464 |
CTD |
| G |
Pgc |
progastricsin (pepsinogen C) |
|
increases expression |
ISO |
9 |
8,723,620 |
8,731,837 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pir |
pirin (iron-binding nuclear protein) |
|
increases expression |
ISO |
X |
50,864,981 |
50,974,861 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
increases expression |
ISO |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases activity |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases activity |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Ptgr1 |
prostaglandin reductase 1 |
|
decreases expression |
ISO |
5 |
77,010,809 |
77,029,326 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptms |
parathymosin |
|
increases expression |
ISO |
4 |
161,041,242 |
161,045,145 |
RGD:6480464 |
CTD |
| G |
Rgcc |
regulator of cell cycle |
|
increases expression |
ISO |
15 |
60,451,831 |
60,452,229 |
RGD:6480464 |
CTD |
| G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
|
decreases expression |
ISO |
3 |
153,849,825 |
153,890,111 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc22a15 |
solute carrier family 22, member 15 |
|
decreases expression |
ISO |
2 |
196,953,291 |
197,013,763 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
increases expression |
ISO |
4 |
159,210,116 |
159,221,169 |
RGD:6480464 |
CTD |
| G |
Slc6a14 |
solute carrier family 6 (amino acid transporter), member 14 |
|
increases expression |
ISO |
X |
12,048,993 |
12,072,434 |
RGD:6480464 |
CTD |
| G |
Slc6a8 |
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
|
increases expression |
ISO |
X |
159,570,789 |
159,580,093 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
decreases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Smim14 |
small integral membrane protein 14 |
|
decreases expression |
ISO |
14 |
45,477,213 |
45,520,785 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
decreases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
increases expression |
ISO |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
decreases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tpm4 |
tropomyosin 4 |
|
increases expression |
ISO |
16 |
18,108,914 |
18,122,956 |
RGD:6480464 |
CTD |
| G |
Trim16 |
tripartite motif-containing 16 |
|
increases expression |
ISO |
10 |
48,987,004 |
49,009,696 |
RGD:6480464 |
CTD |
| G |
Ttyh3 |
tweety homolog 3 (Drosophila) |
|
increases expression |
ISO |
12 |
14,463,541 |
14,491,939 |
RGD:6480464 |
CTD |
| G |
Tube1 |
tubulin, epsilon 1 |
|
decreases expression |
ISO |
20 |
43,280,097 |
43,298,415 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
decreases expression |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
Term paths to the root
|